CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,628,000 | +54.8% | 164,400 | +20.8% | 0.36% | +10.1% |
| Q1 2020 | $1,052,000 | +21.1% | 136,098 | +26.6% | 0.33% | +38.6% |
| Q4 2018 | $869,000 | -54.2% | 107,531 | -26.9% | 0.24% | -16.3% |
| Q3 2018 | $1,899,000 | -6.8% | 147,184 | -17.6% | 0.28% | -12.1% |
| Q2 2018 | $2,037,000 | +236.1% | 178,690 | +107.9% | 0.32% | +217.8% |
| Q1 2018 | $606,000 | – | 85,967 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skylands Capital, LLC | 815,869 | $3,141,000 | 0.46% |
| Sargent Investment Group, LLC | 499,010 | $1,921,000 | 0.36% |
| Anson Funds Management LP | 74,440 | $287,000 | 0.33% |
| One68 Global Capital, LLC | 39,241 | $151,000 | 0.33% |
| Granahan Investment Management | 678,618 | $2,613,000 | 0.12% |
| Winning Points Advisors, LLC | 30,000 | $115,000 | 0.07% |
| Avenir Corp | 150,600 | $580,000 | 0.06% |
| HighMark Wealth Management LLC | 10,000 | $38,000 | 0.04% |
| Wealthcare Advisory Partners LLC | 62,279 | $240,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 64,970 | $250,000 | 0.03% |